Atomistry » Chlorine » PDB 4cqb-4d0l » 4crc
Atomistry »
  Chlorine »
    PDB 4cqb-4d0l »
      4crc »

Chlorine in PDB 4crc: Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design

Enzymatic activity of Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design

All present enzymatic activity of Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design:
3.4.21.27;

Protein crystallography data

The structure of Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design, PDB code: 4crc was solved by J.Sandmark, L.Oster, O.Fjellstrom, S.Akkaya, H.G.Beisel, P.O.Eriksson, K.Erixon, D.Gustafsson, U.Jurva, D.Kang, D.Karis, W.Knecht, V.Nerme, I.Nilsson, T.Olsson, A.Redzic, R.Roth, A.Tigerstrom, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 41.7 / 1.60
Space group I 2 3
Cell size a, b, c (Å), α, β, γ (°) 117.760, 117.760, 117.760, 90.00, 90.00, 90.00
R / Rfree (%) 18.5 / 21.3

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design (pdb code 4crc). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design, PDB code: 4crc:

Chlorine binding site 1 out of 1 in 4crc

Go back to Chlorine Binding Sites List in 4crc
Chlorine binding site 1 out of 1 in the Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Creating Novel F1 Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1245

b:15.8
occ:1.00
CL A:OTM1245 0.0 15.8 1.0
C30 A:OTM1245 1.7 16.1 1.0
C31 A:OTM1245 2.7 16.0 1.0
C29 A:OTM1245 2.7 16.2 1.0
O A:VAL227 3.5 14.1 1.0
O A:TRP215 3.5 14.9 1.0
N A:VAL227 3.6 14.6 1.0
CA A:GLY226 3.7 16.6 1.0
CG2 A:THR213 3.7 12.9 1.0
CZ A:TYR228 3.8 14.6 1.0
CB A:ALA190 3.8 15.2 1.0
C A:GLY226 3.9 15.7 1.0
OH A:TYR228 4.0 15.5 1.0
CE1 A:TYR228 4.0 14.1 1.0
C32 A:OTM1245 4.0 16.5 1.0
C28 A:OTM1245 4.0 16.7 1.0
C A:TRP215 4.1 15.3 1.0
N A:TRP215 4.1 14.7 1.0
OD1 A:ASP189 4.1 21.1 1.0
N A:SER214 4.2 13.7 1.0
CE2 A:TYR228 4.2 14.4 1.0
C A:VAL227 4.2 14.6 1.0
CA A:TRP215 4.5 15.3 1.0
CD1 A:TYR228 4.5 14.4 1.0
C33 A:OTM1245 4.5 16.7 1.0
CA A:VAL227 4.6 14.6 1.0
CA A:THR213 4.7 12.8 1.0
CD2 A:TYR228 4.7 14.2 1.0
C A:SER214 4.7 14.6 1.0
O A:HOH2161 4.8 23.5 1.0
CB A:THR213 4.8 12.5 1.0
C A:THR213 4.8 13.1 1.0
CG A:TYR228 4.8 14.0 1.0
CA A:ALA190 4.8 15.5 1.0
N A:GLY216 4.9 16.3 1.0
N A:ALA190 4.9 16.1 1.0
O A:GLY226 4.9 16.0 1.0

Reference:

O.Fjellstrom, S.Akkaya, H.Beisel, P.Eriksson, K.Erixon, D.Gustafsson, U.Jurva, D.Kang, D.Karis, W.Knecht, V.Nerme, I.Nilsson, T.Olsson, A.Redzic, R.Roth, J.Sandmark, A.Tigerstrom, L.Oster. Creating Novel Activated Factor XI Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One V. 10 13705 2015.
ISSN: ISSN 1932-6203
PubMed: 25629509
DOI: 10.1371/JOURNAL.PONE.0113705
Page generated: Sun Jul 21 11:31:00 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy